ImmuPharma plc (IMM.L)
GBp 1.11
(0.68%)
GBp 1.11
(0.68%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -1.36 Million | -2.34 Million | -4.83 Million | -3.32 Million | -4.22 Million | -4.72 Million |
| Net Income | -2.92 Million | -3.02 Million | -6.58 Million | -5.58 Million | -6.28 Million | -8.08 Million |
| Depreciation & Amortization | 37.6 Thousand | 117.56 Thousand | 114.11 Thousand | 170.95 Thousand | 88.03 Thousand | 133.08 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 140.23 Thousand | 159.87 Thousand | 616.42 Thousand | 1.57 Million | 1.98 Million | 2.05 Million |
| Change in working capital | 469.6 Thousand | -428.77 Thousand | 631.59 Thousand | 105.54 Thousand | -230.94 Thousand | 166.37 Thousand |
| Other non-cash items | 658.81 Thousand | 833.22 Thousand | 391.64 Thousand | 405.16 Thousand | 219.63 Thousand | 1 Million |
| Investing Cash Flow | 185.73 Thousand | -77.42 Thousand | -50.28 Thousand | -569.2 Thousand | -101.36 Thousand | -2.09 Million |
| Investments in PPE | 2.00 | -106 Thousand | -50.93 Thousand | -360.29 Thousand | -107.11 Thousand | -102.88 Thousand |
| Acquisitions | 185.73 Thousand | - | - | - | - | - |
| Investment purchases | - | - | - | -250 Thousand | - | -2 Million |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 188.76 Thousand | 28.58 Thousand | 651.00 | 41.08 Thousand | 5743.00 | 12.49 Thousand |
| Financing Cash Flow | 722.09 Thousand | 1.54 Million | 702.04 Thousand | 8.37 Million | 325.71 Thousand | 9.14 Million |
| Debt repayment | - | - | -722.97 Thousand | -836.6 Thousand | -89.21 Thousand | -138.88 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 1.35 Million | 2.35 Million | 3.55 Million | 8 Million | 2.65 Million | 10 Million |
| Other Financing Activities | -637.31 Thousand | -803.17 Thousand | -2.12 Million | 1.2 Million | -2.24 Million | -713.92 Thousand |
| Accounts receivables | 255.8 Thousand | -296.38 Thousand | -265.2 Thousand | -8380.00 | 177.87 Thousand | 404.72 Thousand |
| Accounts payables | 213.79 Thousand | -132.39 Thousand | 896.79 Thousand | 113.92 Thousand | -408.81 Thousand | 15.15 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 213.79 Thousand | - | - | - | - | -253.5 Thousand |
| Cash at beginning of period | 667.81 Thousand | 1.64 Million | 5.86 Million | 1.36 Million | 4.91 Million | 2.72 Million |
| Cash at end of period | 208.48 Thousand | 667.81 Thousand | 1.64 Million | 5.86 Million | 1.36 Million | 4.91 Million |
| Capital Expenditure | 2.00 | -106 Thousand | -50.93 Thousand | -360.29 Thousand | -107.11 Thousand | -102.88 Thousand |
| Effect of forex changes on cash | -5783.00 | -104.8 Thousand | -31.27 Thousand | 25.46 Thousand | 450.43 Thousand | -153.68 Thousand |
| Net cash flow / Change in cash | -459.33 Thousand | -981.56 Thousand | -4.21 Million | 4.49 Million | -3.54 Million | 2.18 Million |
| Free Cash Flow | -1.36 Million | -2.45 Million | -4.88 Million | -3.68 Million | -4.32 Million | -4.82 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -193.92 Thousand | -193.92 Thousand | -1.03 Million | -2.92 Million | -1.03 Million | -847.36 Thousand |
| Depreciation & Amortization | 9421.00 | 9421.00 | -10.59 Thousand | 37.6 Thousand | -10.59 Thousand | 58.78 Thousand |
| Deferred income taxes | - | - | - | - | - | -63.66 Thousand |
| Stock-based compensation | 16.34 Thousand | 16.34 Thousand | 6455.00 | 140.23 Thousand | 6455.00 | 63.66 Thousand |
| Change in working capital | -40.96 Thousand | -40.96 Thousand | 119.04 Thousand | 469.6 Thousand | 119.04 Thousand | 117.57 Thousand |
| Other non-cash items | -229.23 Thousand | -229.23 Thousand | 566.56 Thousand | 658.81 Thousand | 566.56 Thousand | 19.55 Thousand |
| Investing Cash Flow | 739.77 Thousand | 739.77 Thousand | 93.64 Thousand | 185.73 Thousand | 93.64 Thousand | 732.00 |
| Investments in PPE | 2.00 | - | - | - | - | - |
| Acquisitions | - | - | - | 185.73 Thousand | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | 1.47 Million | - | - | - | - | - |
| Other Investing Activities | 739.77 Thousand | 739.77 Thousand | 93.64 Thousand | 188.76 Thousand | 93.64 Thousand | 732.00 |
| Financing Cash Flow | 146.68 Thousand | 146.68 Thousand | 268.62 Thousand | 722.09 Thousand | 268.62 Thousand | 184.84 Thousand |
| Debt repayment | - | - | - | - | - | -109.00 |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | 1.35 Million | - | - |
| Other Financing Activities | 146.68 Thousand | 146.68 Thousand | 268.62 Thousand | -637.31 Thousand | 268.62 Thousand | 184.95 Thousand |
| Accounts receivables | -40.96 Thousand | -40.96 Thousand | 119.04 Thousand | 255.8 Thousand | 119.04 Thousand | 17.71 Thousand |
| Accounts payables | -293.68 Thousand | - | - | 213.79 Thousand | - | 99.85 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 210.58 Thousand | - | - | 667.81 Thousand | - | 667.81 Thousand |
| Cash at end of period | 1.08 Million | 437.97 Thousand | -1052.00 | 208.48 Thousand | -1052.00 | 210.58 Thousand |
| Capital Expenditure | 2.00 | - | - | - | - | - |
| Effect of forex changes on cash | -10.11 Thousand | -10.11 Thousand | -7583.00 | -5783.00 | -7583.00 | 4691.00 |
| Net cash flow / Change in cash | 873.85 Thousand | 437.97 Thousand | -1052.00 | -459.33 Thousand | -1052.00 | -457.22 Thousand |
| Free Cash Flow | -438.36 Thousand | -438.36 Thousand | -355.74 Thousand | -1.36 Million | -355.74 Thousand | -651.45 Thousand |
ACO-Y
GAZP
1319
TGTX
VVY
MKC